Skip to main content

APX-DIENOGEST, DIENOGEST-STR, DINASANE (Arrow Pharma Pty Ltd)

Product name
APX-DIENOGEST, DIENOGEST-STR, DINASANE
Date registered
Evaluation commenced
Decision date
Approval time
148 (255 working days)
Active ingredients
dienogest
Registration type
New generic medicine
Indication

APX-DIENOGEST, DIENOGEST-STR, DINASANE (tablet) is indicated for the treatment of endometriosis.

Registration process

First generic
First approval of a medicine that contains the same active ingredient as and is bioequivalent to an existing medicine

Help us improve the Therapeutic Goods Administration site